Literature DB >> 11942934

Quality of life in schizophrenia measured by the MOS SF-36 and the Lancashire Quality of Life Profile: a comparison.

C J Meijer1, A H Schene, M W J Koeter.   

Abstract

OBJECTIVE: To compare two Quality of Life (QoL) instruments on reliability, feasibility and conceptual overlap in a group of schizophrenic out-patients.
METHOD: The Lancashire Quality of Life Profile (LQoLP) and the MOS SF-36 were used to assess the QoL of 143 schizophrenic out-patients.
RESULTS: Feasibility and reliability for both instruments were satisfying. Second order factor analysis on 10 LQoLP and eight MOS SF-36 scales resulted in three factors: one health related QoL factor and two general QoL factors; an internal and an external factor.
CONCLUSION: QoL measures in schizophrenia studies are not exchangeable. Validity of a specific QoL instrument depends upon the purpose of the study. The LQoLP allows suggestions for specific improvements in mental health care for long-term psychiatric patients. The SF-36 is a good choice when comparison with other patient groups on health related QoL is relevant.

Entities:  

Mesh:

Year:  2002        PMID: 11942934     DOI: 10.1034/j.1600-0447.2002.1198.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  17 in total

Review 1.  A review and critique of studies reporting utility values for schizophrenia-related health states.

Authors:  Ifigeneia Mavranezouli
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia.

Authors:  C W Law; Eric Y H Chen; Eric F C Cheung; Raymond C K Chan; Josephine G W S Wong; Cindy L K Lam; K F Leung; Molly S M Lo
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

3.  The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common?

Authors:  Uwe Konerding; Jörn Moock; Thomas Kohlmann
Journal:  Qual Life Res       Date:  2009-09-01       Impact factor: 4.147

4.  Correlates of quality of life in an Arab schizophrenia sample.

Authors:  Muhammad Ajmal Zahid; J U Ohaeri; A S Elshazly; M A Basiouny; H M Hamoda; R Varghese
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-02       Impact factor: 4.328

5.  A model of subjective quality of life for outpatients with schizophrenia and other psychoses.

Authors:  Mona Eklund; Martin Bäckström
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

6.  The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial.

Authors:  Reinhold Kilian; Matthias C Angermeyer
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

7.  Systematic review of global functioning and quality of life in people with psychotic disorders.

Authors:  A G Nevarez-Flores; K Sanderson; M Breslin; V J Carr; V A Morgan; A L Neil
Journal:  Epidemiol Psychiatr Sci       Date:  2018-10-01       Impact factor: 6.892

8.  Validation of the Chinese version of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) in Taiwanese patients with schizophrenia.

Authors:  Po-Ju Kuo; Mei-Jin Chen-Sea; Ru-Band Lu; Ming-Shun Chung; Chien-Cheng Kuo; Wei-Che Huang; Hui-Ing Ma
Journal:  Qual Life Res       Date:  2007-09-21       Impact factor: 4.147

9.  Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia.

Authors:  Carin J Meijer; Maarten W J Koeter; Mirjam A G Sprangers; Aart H Schene
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-10-30       Impact factor: 4.328

10.  Physical and mental health-related quality of life among older people with schizophrenia.

Authors:  David P Folsom; Colin Depp; Barton W Palmer; Brent T Mausbach; Shahrokh Golshan; Ian Fellows; Veronica Cardenas; Thomas L Patterson; Helena C Kraemer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2009-01-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.